Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
1.230
-0.100 (-7.52%)
At close: Nov 13, 2026, 4:00 PM EST
1.250
+0.020 (1.63%)
After-hours: Nov 13, 2026, 4:25 PM EST
Kiora Pharmaceuticals Revenue
Kiora Pharmaceuticals had revenue of $1.00M in the quarter ending September 30, 2026. That makes Kiora Pharmaceuticals the 43,645th largest company in the world by revenue and 6,106th in the United States.
Revenue (ttm)
$1.00M
Revenue Growth
n/a
P/S Ratio
7.83
Revenue / Employee
$76,923
Employees
13
Market Cap
7.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 16.02M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 12.06K | -2.67M | -99.55% |
| Dec 31, 2019 | 2.69M | 1.03M | 62.54% |
| Dec 31, 2018 | 1.65M | 1.25M | 305.51% |
| Dec 31, 2017 | 407.52K | -261.74K | -39.11% |
| Dec 31, 2016 | 669.26K | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ensysce Biosciences | 6.19M |
| Immuron | 5.34M |
| Cerenome | 4.20M |
| Vistagen Therapeutics | 2.50M |
| Longeveron | 1.17M |
| Addex Therapeutics | 102.81K |
| Soligenix | 2.34K |
KPRX News
- 3 days ago - Kiora Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 3 days ago - Kiora Pharmaceuticals Earnings release: Q3 2026 - Filings
- 17 days ago - Kiora Pharmaceuticals Slides: Corporate presentation - Filings
- 2 months ago - Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation - Newsfile Corp
- 3 months ago - Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Newsfile Corp
- 3 months ago - Kiora Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 3 months ago - Kiora Pharmaceuticals Earnings release: Q2 2026 - Filings
- 3 months ago - Kiora Pharmaceuticals Slides: Q2 2026 - Filings